Joongheun Pharmaceutical Showcases Innovative Lorient Products at Korea Derma 2024

Joongheun Pharmaceutical announced that it will participate in ‘Korea Derma 2024’, which opens on November 1 in Seoul, where it plans to introduce its flagship products, ’Lorient Filler’ and ’Lorient Element’, through expert presentations.

Korea Derma is an academic event where dermatologists from around the world gather to share the latest insights. At this event, Joongheun Pharmaceutical aims to promote its Lorient products, which are designed to assist with anti-aging treatments.

According to Joongheun Pharmaceutical, the Lorient products are backed by around 15 scientific papers demonstrating their efficacy.

A recent paper published in the international journal Polymers revealed that Lorient Filler is among the global filler products with a low hyaluronic acid modification rate and efficient cross-linking. The modification rate and cross-linking of hyaluronic acid are known to directly impact the occurrence of side effects and the longevity of the treatment.

Additionally, the Lorient Element, officially launched this year, targets existing skin booster products that contain ingredients mixed without specific purposes. Instead, Lorient Element comprises only four ingredients specifically chosen by dermatologists for actual use in pigment treatment.

At this year's Korea Derma, renowned British plastic surgeon Sabrina Shah-Desai will give a presentation titled “Accelerated Management of Hyperpigmentation with Lorient Element.“ The presentation will focus on the product's excellent efficacy in pigmentation treatment and its safe, scientifically proven combination of ingredients.

Domestic experts will also be presenting. Shin Ji-yeon, director of Doctors Dermatology Clinic in Incheon Geomdan, will give a lecture on “Lips, Nasolabial Folds, and Chin Filler Treatment! All in One with Lorient Filler“, detailing how Lorient Filler can be effectively applied to the lips, nasolabial folds, and chin areas.

Additionally, Ahn In-soo, director of Siheung Human Dermatology Clinic, will present “Resolving the Last 2% of Stubborn Pigmentation with Lorient Element“, providing specific clinical cases on how Lorient Element can address persistent pigmentation issues.

A representative from Joongheun Pharmaceutical stated, “Lorient products, proven in excellence based on scientific evidence, are already recognized for their value in the market. This conference will further strengthen our position in the global aesthetic market by engaging with domestic and international experts.“